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AMPA-type glutamate receptors (AMPARs) are
responsible for a variety of processes in the mamma-
lianbrain including fast excitatory neurotransmission,
postsynaptic plasticity, or synapse development.
Here,withcomprehensiveandquantitativeproteomic
analyses, we demonstrate that native AMPARs are
macromolecular complexes with a large molecular
diversity. This diversity results from coassembly of
the known AMPAR subunits, pore-forming GluA and
three types of auxiliary proteins, with 21 additional
constituents, mostly secreted proteins or transmem-
brane proteins of different classes. Their integration
at distinct abundance and stability establishes the
heteromultimeric architecture of native AMPAR
complexes: a defined core with a variable periphery
resulting in an apparent molecular mass between
0.6 and 1 MDa. The additional constituents change
the gating properties of AMPARs and provide links
to the protein dynamics fundamental for the complex
role of AMPARs in formation and operation of gluta-
matergic synapses.
INTRODUCTION
Fast excitatory neurotransmission in the mammalian brain
largely relies on AMPA receptors (AMPARs) that control funda-
mental aspects of development and signal transduction in gluta-
matergic synapses. During the early phase of synaptogenesis,
AMPARs are recruited to dendritic sites of contact with axons
where they promote both formation and maturation of synapses
(McAllister, 2007; McKinney, 2010). In established synapses,
AMPARs mediate the fast excitatory postsynaptic current
(EPSC) that initiates propagation of the electrical signal and
controls Ca2+ entry into the postsynaptic spine (Cull-Candy
et al., 2006; Garaschuk et al., 1996; Jonas and Spruston, 1994;
Raman and Trussell, 1992; Sah et al., 1990; Silver et al., 1992).The time course and the amplitude of the AMPAR-mediated
EPSCs are quite variable among neurons and strongly depend
upon the gating properties of the receptor channels (Conti and
Weinberg, 1999; Jonas, 2000). The number of AMPARs in the
postsynaptic membrane is determined by trafficking and endo/
exocytic processes (Bredt and Nicoll, 2003; Carroll et al., 2001;
Choquet, 2010; Choquet and Triller, 2003; Shepherd and Huga-
nir, 2007). All of these processes appear to be regulated via post-
translational modifications and protein interactions and together
are thought to endow excitatory synaptic transmission with
the activity-dependent plasticity underlying learning, memory,
and/or maintenance of synapses (Derkach et al., 2007; Malenka
and Nicoll, 1999; Malinow and Malenka, 2002; Newpher and
Ehlers, 2008).
On the molecular level, the complexity in the cell biology of
AMPARs is met by a number of distinct protein constituents:
native AMPARs are assembled from the pore-forming GluA1-4
proteins (Collingridge et al., 2009; Hollmann and Heinemann,
1994; Seeburg, 1993) and at least three types of auxiliary
subunits, the transmembrane AMPAR regulatory proteins
(TARPs g-2, g-3, g-4, g-5, g-7, g-8; Cho et al., 2007; Milstein
et al., 2007; Soto et al., 2009; Tomita et al., 2003), the cornichon
homologs (CNIH-2, CNIH-3; Schwenk et al., 2009), and the
CKAMP44 protein (von Engelhardt et al., 2010). Alone or in
combination, these auxiliary subunits control the gating and
pharmacology of the AMPARs and profoundly impact their
biogenesis and protein processing (Bats et al., 2007; Chen
et al., 2000; Gill et al., 2011; Harmel et al., 2012; Kato et al.,
2010; Schober et al., 2011; Schwenk et al., 2009; Soto et al.,
2007; Tomita et al., 2005; Vandenberghe et al., 2005; von Engel-
hardt et al., 2010).
It is not clear, however, whether these auxiliary proteins
represent the whole set of building blocks for native AMPARs
or whether they contain additional yet unknown protein constit-
uents. Likewise, quantitative data on the subunit composition
of native AMPAR complexes are not yet available. This informa-
tion may be obtained from comprehensive and quantitative
proteomic analyses as have recently been presented for the
Cav2 family of voltage-gated calcium channels (Mu¨ller et al.,
2010).Neuron 74, 621–633, May 24, 2012 ª2012 Elsevier Inc. 621
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High-Resolution Architecture of Native AMPARsHere we used two orthogonal biochemical strategies, multiepi-
tope and target knockout-controlled affinity purifications (Bildl
et al., 2012; Mu¨ller et al., 2010) and newly developed high-
resolution quantitative analyses of protein complexes separated
on native gels (BN-MS), for investigation of the subunit composi-
tion of AMPARs from total brain. These analyses unravel native
AMPARs as macromolecular complexes of unanticipated
complexity and identify 21 novel protein constituents, mostly
transmembrane or secreted proteins of low molecular mass and
with distinct functions. Subsequent studies using antibody shift
assays, binding studies, and electrophysiological recordings
reveal the architecture of native AMPARs and demonstrate that
properties and function of the receptor complexes may be quite
distinct stronglydependingon theparticular subunit composition.
RESULTS
Multiepitope Proteomic Analysis of AMPAR Complexes
in the Brain
For comprehensive proteomic analysis of native AMPARs, we
performed multiepitope affinity purifications (ME-APs) (Mu¨ller
et al., 2010; Schwenk et al., 2010) with ten different antibodies
(ABs) specific for the GluA1-4 proteins on membrane fractions
prepared from total brains of adult rats, wild-type (WT) mice,
and AB-target knockout mice (see Experimental Procedures).
For ME-APs themembrane fractions were treated with detergent
buffers of either mild (CL-47) or intermediate (CL-91) stringency
(Mu¨ller et al., 2010; Schwenk et al., 2010) solubilizing 40% and
100% of the total pool of AMPARs, respectively (Figures S1A
and S1B). These buffers were selected as the two extremes in
a test series probing the solubilization efficiency of various
CL-buffers as well as of RIPA and Triton X-100, the buffers most
widely used with AMPARs (Kim et al., 2010; Shi et al., 2009,
2010; Vandenberghe et al., 2005; solubilization efficiency of
60%, Figure S1B). Both CL-47 and CL-91 preserved high-
molecular-weight AMPAR complexes (Schwenk et al., 2009) as
demonstrated by blue native polyacrylamide gel electrophoresis
(BN-PAGE); the AMPAR complexes focused over an apparent
molecular mass range of 0.4 MDa under either condition,
although they appeared slightly smaller in CL-91 than in CL-47
(Figure 1A). Total eluates of APs with the anti-GluA ABs or with
poolsofpreimmunization immunoglobulinsG (IgG)wereanalyzed
by high-resolution nanoflow liquid chromatography tandemmass
spectrometry (nano-LCMS/MS),whichprovideddata onboth the
identity and the amount of proteins. Protein amounts were deter-
mined from the peak volumes (PVs) of their best-correlating
tryptic peptides (TopCorr method [Bildl et al., 2012]; see also
Experimental Procedures), a label-free quantification method
offering a linear dynamic range of up to four orders of magnitude
(Bildl et al., 2012; Mu¨ller et al., 2010; Schwenk et al., 2010).
The results of these MS analyses showed that AMPARs were
retained in all APs with high efficiency as reflected by the PV
values and the extensive coverage provided for the primary
sequence of the GluA1-4 proteins by the MS/MS-identified
peptides (relative sequence coverage of 90%, 95%, 95%,
83% for GluA1 to GluA4, respectively; Tables S1–S3; detailed
information on all aspects related to MS analyses were depos-
ited at http://www.channel-proteomes.com/projects). The other622 Neuron 74, 621–633, May 24, 2012 ª2012 Elsevier Inc.proteins identified by mass spectrometry in the anti-GluA APs
(and surpassing the threshold PV, see Experimental Procedures)
were evaluated for both their specificity and consistency of
copurification with the GluA proteins based on the quantitative
data of protein amounts. Specificity of copurification was deter-
mined from abundance ratio plots using both target knockouts
and preimmunization IgGs as negative controls (upper-right
quadrant in Figure 1B; Table S3; Bildl et al., 2012; Mu¨ller et al.,
2010). Consistency was assessed by the number of specific
copurifications of a given protein across the anti-GluA APs;
a protein was considered consistent if it was specifically retained
in at least five (out of ten) or three (out of five) anti-GluA APs using
solubilization with CL-91 and CL-47, respectively.
Together, the criteria abundance threshold, specificity,
consistency, and confirmation by at least one of the knockout
controls defined a sharp-profiled proteome (Figure 1C), identi-
fying 34 (out of 1,711 detected) proteins as high-confidence
constituents of native AMPARs in the rodent brain (Table 1). As
summarized in Figure 1D, these constituents comprise the afore-
mentioned AMPAR subunits GluA1-4, five members of the TARP
family (g-5 was unambiguously detected in only three out of 15
APs, albeit in small amounts), CNIHs 2,3, and CKAMP44 as
well as another 22 proteins of which only DLG4 (or PSD95) has
been previously described as an AMPAR interactor (Chen
et al., 2000). Similar to the known auxiliary subunits, the majority
of the newly identified AMPAR constituents are low-molecular-
weight proteins (between 15.3 and 55.4 kDa; Figure 1D) and
most of them were copurified effectively under both solubiliza-
tion conditions resulting in a marked relative coverage of their
primary sequences (between 25% and 100%, Figure 1D). Inter-
estingly, 12 of these new constituents (out of 21) are transmem-
brane (TM) proteins of different classes (1–8 TM domains), while
five are secreted and four are cytoplasmic proteins (Table 1).
Robust association of these proteins with native AMPARs was
corroborated in reverse APs where ABs targeting a selected
set of known and newly identified AMPAR constituents replaced
the anti-GluA ABs. As shown in Figure S1C, all of the ABs effec-
tively retained the GluA proteins together with many of the other
AMPAR proteome constituents.
Quantification of Subunit Composition by BN-Mass
Spectrometry
While ME-APs are suited to reliably identify constituents of
proteinassemblies, theymaynot entirely reflect their nativeabun-
dancesandstoichiometries,mainly due to the inherentproperties
of ABs (Mu¨ller et al., 2010; Schulte et al., 2011).We therefore used
an AB-free BN-MS approach (Remmerie et al., 2011; Wessels
et al., 2009) exploiting the sharp focusing of AMPAR complexes
in the BN-PAGE (Figure 1A). Sections of native gel regions
harboring the AMPARs (from total brain of adult rats) were sliced
with a cryotome (thickness of slices 400 mm) and collected, and
each slice was analyzed individually for its protein composition
by quantitative MS-analysis (Figure 2A; see Experimental Proce-
dures). Together with calibration peptides specific for the identi-
fied AMPAR constituents (Figure 1D) and concatenated into
fusionproteinsat definedstoichiometry (QconCATproteins;Pratt
et al., 2006; Figure S2A, Table S4), this procedure allowed for
quantitative assessment of themolecular composition of AMPAR
number of
proteins
800
400
0
of spe
cific A
Ps
CL-47
identified AMPAR
constituents
background proteins
C
GluA1
GluA2
CNIH2
10-2 10-1 100 101 102 103 104
10-2
10-1
100
101
102
103
104
abundance ratio (rPVWT / GluA1-/-)
ab
un
da
nc
e
ra
tio
(rP
V a
n
ti-
Gl
uA
1
/Ig
G
)
CL-91 CL-47
specific (knock-out controlled)
specific (knock-out control not available)
not confirmed /
not found
55.4
50.7
54.9
31.4
35.2
15.3
35.9
37.3
35.4
24.6
100.6
93.5
80.4
61.5
98.7
101.6
100.4
100.8
35.9
35.5
36.5
31.0
43.5
18.9
18.9
58.1
46.9
67.1
44.7
67.0
38.3
45.2
90.0
20.5
Noelin
1
2
3
PRRT 12
Neuritin
GSG1-l protein
C9orf4
Brorin
Brorin-2l
DLG
1
3
4
MAGUKp55-2
1
2
3
4
GluA
TARP
CNIH-
MW
(kDa)ant
i-G
luA
1-a
an
ti-G
luA
1-
b
CKAMP
LRRT-4
PORCN
PIP-PP SAC1
lipase ABHD-6
lipase ABHD-12
CPT-1
Rap-2b
γ-2
γ-3
γ-4
γ-7
γ-8
2
3
52
44
an
ti-G
luA
1-c
an
ti-G
luA
2-
a
an
ti-G
luA
2-b
an
ti-G
luA
2-
c
an
ti-G
luA
2/3
an
ti-G
luA
3
an
ti-G
luA
4-
a
an
ti-G
luA
4-
b
DA
B
150
100
0.61.2app. mol. mass (MDa)
MW
(kDa)
anti-GluA2Western
1. dimension
(BN-PAGE)
2.dim
e
n
sio
n
(SDS-PAG
E)
CL-91
CL-47 150100
rel.
seq.
coverage
0.71
0.74
0.53
1.00
0.43
0.77
1.00
0.68
0.68
0.45
0.71
0.25
0.81
0.38
0.90
0.95
0.95
0.83
0.67
0.72
0.77
0.73
0.77
0.69
0.70
0.62
0.48
0.44
0.36
0.63
0.89
0.75
0.54
0.72
Figure 1. ME-AP Proteomics Identify the Protein Constituents of Native AMPARs
(A) Two-dimensional gel separation of AMPAR complexes from rat brain solubilized with CL-91 and CL-47; both gel separations were western-probed with the
indicated antibody. Size (BN-PAGE) and molecular weight (SDS-PAGE) are as indicated.
(B) Two-dimensional logarithmic abundance-ratio plot illustrating the medians of PV ratios (rPV) obtained for any protein in APs from rat membranes with the
anti-GluA1-a AB versus IgG (y axis) and in anti-GluA1-a APs from mouse membranes of WT versus GluA1 knockout animals (x axis). Gray bars (rPVs of 10)
represent the specificity threshold for this AB on either rPV scale and place specifically purified proteins in the upper-right quadrant. Red dots denote finally
annotated AMPAR constituents (D, Table 1); black dots symbolize all other proteins. Red dot in the lower-right and black dots in the upper-right quadrant
represent peculiarities of the anti-GluA1-a AP.
(C) Three-dimensional plot illustrating the consistency of specifically copurified proteins detected in the anti-GluA APs performed with CL-91 (10 APs) and CL-47
(5 APs). Blue lines indicate the consistency thresholds given in the text, and numbers are the count of APs that specifically copurified a given protein. Red bars
refer to the counts of finally annotated AMPAR constituents, and gray bars denote counts of background proteins; the four proteins surpassing the consistency
threshold of CL-47 failed confirmation by knockout controls. Note the sharp discrimination between AMPAR constituents and background.
(D) Table summarizing the results for all of the finally annotated AMPAR constituents across the 15 APs performed with the indicated anti-GluA ABs. Color coding
given in the upper left; MW and relative coverage of the primary sequence as indicated on the right.
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High-Resolution Architecture of Native AMPARscomplexes of a given apparent molecular mass (Figure 2A; see
Experimental Procedures).
Figure 2B shows the resulting abundance profiles obtained
from 81 consecutive gel slices for the most ample constituents
of AMPARs solubilized with CL-47. Thus, the major portion of
AMPAR complexes exhibited an apparent molecular mass of
about 0.6–1.0 MDa, markedly exceeding the size of the GluA
tetramers (mass of0.5 MDa, Figure S2C). For the pore-forming
subunits, BN-MS revealed an abundance sequence of GluA2 >
GluA1 > GluA3 > GluA4, with the molecular amount of GluA2
being equal to the sum of the other GluAs (Figure 2B, upperpanel). Among the known auxiliary subunits, TARP g-8 and
CNIH-2 were by far the most abundant (Figures 2B and 2E).
Comparison of the abundance value determined for all TARP
and CNIH proteins with that obtained for the entire pool of
AMPARs (defined as GluA tetramers, GluAtetra) yielded a ratio
of about 4:1 (Figure 2C), strongly suggesting that, on average,
AMPAR complexes contain up to four TARP or CNIH proteins
in line with previous reports on heterologously expressed
AMPARs (Kim et al., 2010; Shi et al., 2009).
Moreover, the BN-MS approach revealed cosegregation of
the newly identified AMPAR constituents with the GluA proteins,Neuron 74, 621–633, May 24, 2012 ª2012 Elsevier Inc. 623
Table 1. Protein Constituents of Native AMPARs as Identified by ME-APs
Protein ID AlternativeName(s)
Acc. No.
(SwissProt)Name
GluA1 AMPA-type glutamate receptor 1 GluR-A P19490
GluA2 AMPA-type glutamate receptor 2 GluR-B P19491
GluA3 AMPA-type glutamate receptor 3 GluR-C P19492
GluA4 AMPA-type glutamate receptor 4 GluR-D P19493
TARP γ-2 Transmembrane AMPA-regulatory
protein γ-2
Stargazin O88602
TARP γ-3 TARP γ-3 Q8VHX0
TARP γ-4 TARP γ-4 Q8VHW9
TARP γ-7 TARP γ-7 P62957
Noelin2 Noelin-2 Q8BM13Olfactomedin-2
TARP γ-8 TARP γ-8 Q8VHW5
CNIH-2 protein cornichon homolog 2 Q5BJU5
CNIH-3 protein cornichon homolog 3 Q6ZWS4
CKAMP44 Cystine-knot AMPAR modulating protein of 44 kDa Q9CZN4Protein shisa-9
Q3UH99Protein shisa-6CKAMP52 Cystine-knot AMPAR modulating protein of 52 kDa
Q9WV34Protein MPP2MAGUKp55-2 MAGUK p55 subfamily member 2
Q62696SAP-97DLG1 Disks large homolog 1
Q62936SAP-102DLG3 Disks large homolog 3
Q62108PSD-95, SAP-90DLG4 Disks large homolog 4
Q6MG82NG-5, SynDIG4PRRT1 Proline-rich transmembrane protein 1
Q7Z6L0PRRT2 Proline-rich transmembrane protein 2
Q62609Noelin1 Noelin-1 Olfactomedin-1,
Pancortin
Noelin3 Noelin-3 P63057Olfactomedin-3
Neuritin Neuritin O08957
GSG1-l protein Germ cell-specific gene 1-like protein Q6UXU4
C9orf4 Uncharacterized protein C9orf4 Q9P0K9brain protein CG-6
Brorin Brorin, von Willebrand factor C domain-
containing protein 2
Q8C8N3brain-specific
chordin-like protein
Brorin-2l von Willebrand factor C domain-
containing protein 2-like
Q505H4
LRRT4 Leucine-rich repeat transmembrane neuronal protein 4 Q80XG9
PORCN Probable protein-cysteine N-palmitoyltransferase
porcupine
Q9JJJ7Porc, Ppn
PIP-PP SAC1 Phosphatidylinositide phosphatase SAC1 Q9EP69
lipase ABHD-6 Monoacylglycerol lipase ABHD6 Q8R2Y0
lipase ABHD-12 Monoacylglycerol lipase ABHD12 Q99LR1
CPT-1 Carnitine O-palmitoyltransferase 1 (brain isoform) Q8BGD5CPT-1C
Rap-2b Ras-related protein Rap-2b P61227
CPG-15
transmembrane secreted cytoplasmic
Accession numbers refer to the UniProt/SwissProt database; protein classification is given by the color-coding at the bottom.
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Figure 2. BN-MS Quantifies Subunit Composition of Native AMPAR Complexes of Given Molecular Mass
(A) Scheme illustrating the BN-MS approach used for high-resolution analysis of the subunit composition of native AMPARs (details in the text and Experimental
Procedures).
(B and C) Abundance-mass profiles determined for AMPAR complexes solubilized with CL-47. Each data point represents the amount determined for the
respective protein in one gel slice (total of 81 gel slices); symbols are as indicated. GluAtetra (black line) refers to the summed amounts of GluA1-4 divided by 4, and
the red line in (C) is the sum of protein amounts determined for CNIHs 2,3 and TARPs g-2,3,4,7,8. Note the distinct profiles obtained for GSG1-l, C9orf4 and
Noelin-1.
(D) Abundance-mass profiles as in (C) but determined for AMPAR complexes solubilized with CL-48 (total of 69 gel slices).
(E) Bar graph illustrating total relativemolecular abundance (integral over the investigatedmass range) of the indicated AMPAR constituents determined in buffers
CL-48 (red) and CL-47 (blue); asterisks denote missing data.
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High-Resolution Architecture of Native AMPARsthus providing independent evidence for their robust association
with native AMPAR complexes (Figure 2B, lower panel). As indi-
cated by the abundance-mass profiles, these proteins either
assemble into distinct AMPAR complexes of defined molecular
mass (such as GSG1-l or Noelin1, Figure 2B, lower panel) or
may be integrated into multiple types of complexes extending
over a broader mass range (such as C9orf4 or CKAMP44, Fig-
ure 2B, upper and lower panel). The abundance values of all
newly identified proteins were below those of TARP g-8 and
CNIH-2, but well in the range of the other TARPs, CNIH-3, or
CKAMP44 (Figures 2B and 2E).
Subsequent BN-MS analysis of AMPAR complexes solubi-
lized with buffers of intermediate stringency (CL-48, CL-91) re-
vealed three further important features. First, the difference in
the observed molecular size of AMPARs (Figure 1A), corre-
sponding to 0.1 MDa, is predominantly due to the almost
complete dissociation of TARP g-8 from the AMPARs under
these conditions (Figures 2D and 2E); this quantitative dissocia-
tion was confirmed in density gradient centrifugations (Fig-ure S2B) but was only seen with TARP g-8, while the other
TARPs remained largely unaffected (Figures 2D and 2E; Fig-
ure S2B). Second, some of the newly identified constituents
including LRRT4 and Neuritin were more abundantly detected
with the intermediate stringency buffers (Figure 2E). Third, the
abundance profiles of CNIHs 2,3 and TARPs g-2,3 indicate
that they are predominantly assembled into distinct AMPAR
complexes at an approximate ratio of 3:1 (Figure 2D), in line
with our previous work (Schwenk et al., 2009).
Together, the results from ME-APs and BN-MS indicated that
native AMPARs are in fact formed by a multitude of protein
complexes assembled from up to 34 proteins at distinct
abundance.
Multiple Populations of AMPARComplexes with Distinct
Stability
The assembly of native AMPARs was further investigated in AB-
shift assays separating complexes in BN-PAGE by the additional
mass of target-specific ABs and in APs probing the stability ofNeuron 74, 621–633, May 24, 2012 ª2012 Elsevier Inc. 625
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Figure 3. AMPAR Constituents Cosegregate into Multiple Popula-
tions of AMPAR Complexes
(A) Two-dimensional gel separation of AMPARs as in Figure 1 without (upper
panel) and with ABs specific for either GluA1 (anti-GluA1-b) or GluA2
(anti-GluA2-b; lower two panels, AB-shift assay) added to the membrane
fractions solubilized with CL-91; all gel separations were western-probed with
ABs against the indicated proteins. Arrowheads denote unshifted (gray) or
populations of AMPARs shifted by addition of one or two ABs (red).
(B) AB-shift assay as in (A) but with ABs targeting either CNIHs 2,3 or TARPs
g-2,3,8 and membrane fractions solubilized with CL-47.
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Figure 4. AMPAR Constituents Coassemble into AMPAR
Complexes with Distinct Stability
Heat map indicating the molecular abundance of all AMPAR constituents
determined in anti-GluA1-a APs from membrane fractions solubilized with the
indicated buffers. Stringency of solubilization buffers increased from CL-47 to
CL-114 (Mu¨ller et al., 2010); results obtained with two widely used buffers,
Triton X-100 and RIPA, were added for comparison.
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High-Resolution Architecture of Native AMPARscomplexes by an array of solubilization buffers with different
stringency.
ABs specific for GluA1 and GluA2 shifted the majority of all
GluAs to higher molecular weights (Figure 3A), with the discrete
increments most likely reflecting assembly of at least one or two
of these subunits into the respective AMPARs (also Figure S3);
additionally, both assays revealed a small fraction of AMPARs
devoid of either GluA1 or GluA1-3. The known auxiliary subunits
TARP g-2,3 and CNIH-2,3 were coshifted with both anti-GluAs,
very similar to the GSG1-l protein, as expected for tightly associ-
ated complex constituents (Figure 3A). Interestingly, anti-GluA2,
different from anti-GluA1, shifted the complete pool of GSG1-l,
strongly suggesting preferred association of this newly identified626 Neuron 74, 621–633, May 24, 2012 ª2012 Elsevier Inc.subunit with GluA2-containing AMPARs (Figure 3A). Shift assays
with anti-CNIH-2/3 showed that the majority of AMPARs solubi-
lized at CL-47 (Figure S3B) are associated with the CNIHs (also
Figure 2D), as well as with TARP g-8, while most of the TARP
g-2,3 proteins are assembled into distinct subpopulations of
AMPARs (Figure 3B, upper panel). Moreover, an AB targeting
TARPs g-2,3,8 indicated that virtually all AMPARs solubilized
under these conditions contained at least one of the three TARP
isoforms; AB-shift assays with both anti-TARPg-2/3/8 and anti-
CNIH-2/3 showed that these auxiliary subunits assemble into all
native AMPARs and that the obtained mass shift (Figure S3C) is
in linewith the 4:1 ratio determined forGluA tetramers and TARPs
plus CNIHs (Figure 2C). Notably, the two shift assays in Figure 3B
(separated on the same gel) point toward distinct stoichiometries
of these auxiliary subunits in native AMPARs, up to two CNIHs
and two or more TARPs g-2,3,8 per complex.
The stability of the AMPAR assemblies was assessed by
determining the molecular abundance (using the QconCAT
proteins as in Figure 2) of its constituents retained in anti-
GluA1-a APs under solubilization conditions of increasing
stringency (Mu¨ller et al., 2010) (see Experimental Procedures).
Analysis of the resulting heat map (Figure 4) suggested that the
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Figure 5. The GSG1-l Protein Assembles into
Synaptic AMPARs and Modifies the Gating
Kinetics of Receptor Channels in a Subunit-Depen-
dent Manner
(A) Representative current responses of AMPARs re-
corded upon 1 ms (A) and 100 ms (C) applications of 1 mM
glutamate (indicated above the current trace) in giant
outside-out patches excised from Xenopus oocytes ex-
pressing GluA1i and GluA2i either alone (gray trace) or in
combination with either CNIH-2 (black trace), GSG1-l (red
trace) or both (blue trace). cRNAs of GluA1i and GluA2i,
CNIH-2, and GSG1-l were injected at equal amounts.
Inset: current responses at expanded time scale; agonist
application indicated by the horizontal bar.
(B and D) Bar graphs summarizing the time constants for
deactivation and desensitization (mean ± SD of 6–19
experiments, represented by dots).
(E) Recovery of the same AMPARs as in (A) and (C) from
steady-state desensitization recorded with a double-pulse
protocol (pair of a 100 ms and a 50 ms glutamate pulse
separated by increasing time intervals). Data points are
peak currents recorded during the second pulse and
normalized to the maximal current (recorded during the
first glutamate application). Lines are monoexponential fits
to the data points with the indicated trecovery. Inset: Original
current recordings from GluA1i+A2i+GSG1-l receptors;
red trace is response with a recovery interval of 1024 ms.
(F) Bar graph summarizing the recovery time constants
(mean ± SD of 6–15 experiments, represented by dots).
(G) Immunoelectron micrographs for GluA2,4 and GSG1-l
in the CA3 region of the adult mouse hippocampus de-
tected by postembedding immuno-EM (left panel) and
respective statistics (right panel). Immunoparticles for
GluA2 and GluA4 (10 nm, open arrows) and GSG1-l
(15 nm, filled arrows) weremostly found over asymmetrical
synapses between boutons (b) and dendritic spines (s)
of pyramidal cells and were sparsely detected at extra-
synaptic sites (arrowheads). Note that most im-
munoparticles for GSG1-l were detected in close spatial
relationship (<100 nm) with those for GluA2 and GluA4.
Scale bars are 0.2 mm; bars on the right are mean ± SD
of three independent experiments. PM, intra, and
back denote localization of immunoparticles to the
plasma membrane, intracellular sites, and background,
respectively.
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High-Resolution Architecture of Native AMPARsunderlying protein interactions may be classified into three main
categories: interactions (1) that are largely unaffected by both
intermediate (CL-48, CL-91) and high-stringency conditions
(CL-114; as for CNIHs, Noelins, Neuritin, or PRRTs), (2) that are
markedly reduced under conditions of high stringency (as for
TARPs g-2,3,4,7, GSG1-l, C9orf4, CKAMP44, DLG4, or
PORCN), and (3) interactions mainly preserved at low-stringency
conditions (CL-47; as for TARP g-8, SAC1, DLG1,3, or
CKAMP52). It is noteworthy that the stability of individual interac-
tions was independent of their topology and in most cases not
dependent upon the presence of the abundant auxiliary
subunits. Thus, CNIH-2,3 and other tightly associated constitu-
ents were extensively retained in APs using conditions that did
not preserve assembly of TARP g-8 (Figure 4), or where the
TARP g-8 protein was absent after gene knockout (Figure S4).
In addition, the heat map demonstrated that solubilization withRIPA and Triton X-100 buffers failed to preserve integrity of all
AMPAR complexes, resulting in the loss of a number of constit-
uents (including LRRT4, Neuritin, Brorin, Brorin-2l, CKAMP52,
and PORCN) readily detected in mild and/or intermediate
stringency CL-buffers (Figure 4).
Functional Diversity by Heteromultimerization of
Complex Constituents
The robust integration into defined AMPAR complexes together
with CNIHs and TARPs (Figures 2B, 3, and 4), prompted us to
investigate the functional significance of the GSG1-l protein for
which no primary function has yet been described. Figures 5A
and 5C show representative current responses recorded in giant
outside-out patches from Xenopus oocytes upon 1 ms and
100 ms applications of 1 mM glutamate to AMPARs assembled
either from the flip variants of GluA1 and GluA2 alone or inNeuron 74, 621–633, May 24, 2012 ª2012 Elsevier Inc. 627
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High-Resolution Architecture of Native AMPARscombination with the additional constituents GSG1-l or CNIH-2
or both. Channel activation was similar in all four types of recep-
tors (20%–80% rise times of 0.3 ms), but the time courses of
deactivation (Figure 5A) and desensitization (Figure 5C) were
markedly different, strongly depending upon the subunit compo-
sition of the AMPARs. While GSG1-l alone caused a moderate
slowing of both kinds of channel closure very similar to TARP
g-2 (p < 0.001, Wilcoxon rank test for ± GSG1-l; Figures 5B
and 5D), it largely reversed the pronounced effects of CNIH-2
on the time constants of deactivation and desensitization when
coassembled into the same AMPARs (p < 0.001, Wilcoxon
rank test for CNIH-2 versus CNIH-2+GSG1-l; Figures 5B and
5D). Moreover, receptor channels assembled from GluA1,
GluA2, CNIH-2, andGSG1-l no longer exhibited themarked non-
desensitizing steady-state current (Iss) observed with receptors
composed of the GluA1, GluA2, and CNIH subunits alone (Iss
of 25% ± 10% [mean ± SD, n = 20] and 6% ± 3% [n = 12] for
GluA1+A2+CNIH-2 and GluA1+A2+CNIH-2+GSG1-l channels,
respectively). In contrast to the moderate slowing of desensitiza-
tion, GSG1-l decelerated the reverse process, recovery from
desensitization, by almost 10-fold, and a pronounced slowing
was still present upon addition of CNIH-2, albeit to a lesser
extent (p < 0.001, Wilcoxon rank test for ± GSG1-l and ±
GSG1-l+CNIH-2; Figures 5E and 5F). Interestingly, the dominant
effects of GSG1-l over CNIH-2 in AMPAR gating were not reca-
pitulated in receptors where CNIH-2 was replaced by TARP g-2
(p > 0.7, Wilcoxon rank test for TARP g-2 versus TARP
g-2+GSG1-l; Figures 5B, 5D, and 5F). Conversely, the CNIH-2
effects on gating were only moderately affected by coassembly
of the TARP g-8 subunit(s) (p > 0.7 and p < 0.001 Wilcoxon rank
test for tdesens and trecovery, respectively; Figure S5A).
Together, these results demonstrated that coassembly of
various auxiliary subunits generates AMPARs with quite distinct
functional properties. The particular effects of GSG1-l may
modulate the gating of AMPARs in various regions of the brain
including the hippocampal CA3 region, where postembedding
immunogold electron microscopy colocalized this protein with
GluA2- and/or GluA4-containing AMPARs in dendritic spines of
pyramidal cells (Figures 5G and S5B).
Subunit Composition and Architecture of Native
AMPARs
Next, we used comparison of protein amounts obtained in
anti-GluA APs from WT and GluA1 or GluA2 knockout mice
and quantitative data from BN-PAGE separations (as in Figures
2 and 3, see Experimental Procedures) to probe whether the
identified AMPAR constituents are preferentially associated
with one of the two most abundant GluA subunits. Figure 6A
summarizes the respective results together with the topology
of the complex constituents suggested by public databases.
Accordingly, very few of the AMPAR constituents are preferen-
tially associated with either GluA1 (PRRT1,2) or GluA2 (GSG1-l,
LRRT4, Brorin, and Brorin-2l). Twelve proteins (out of 30) ap-
peared to exclusively associate with AMPARs (over other
complexes in membrane fractions from adult brain) including
the TARPs, CKAMP44, C9orf4, LRRT4, GSG1-l, and the
two CNIH proteins whose complete pool was copurified with
anti-GluAs (Figure S6A).628 Neuron 74, 621–633, May 24, 2012 ª2012 Elsevier Inc.Finally, we combined the proteomic, biochemical and func-
tional data (Figures 1–5) with Pearson correlation analyses
across all data sets (Figure S6B) and binding assays on hetero-
logously coexpressed complex constituents (Figure S6C) to
derive a general (working) model for the assembly of native
AMPARs in the brain. Accordingly, the model projected onto
the recently resolved crystal structure of the GluA tetramer
(Sobolevsky et al., 2009) reflects binding sites, their potential
occupancies, and/or direct interactions of complex constituents,
while exact stoichiometries of individual AMPARs or structural
details are not implicated. As illustrated in Figure 6B, AMPARs
share a common ‘‘inner core’’ that is assembled from four GluAs
and four major auxiliary subunits (Figure 2C) arranged in a two-
fold symmetry determined by the structure of the GluA tetramer
just above the membrane plane (gray line in Figure 6A; Sobolev-
sky et al., 2009). Of the two pairs of distinct binding sites (solid
circles in red and gray, Figure 6B), one is occupied either
by CNIHs 2,3 (70%–80%, Figures 2 and 3) or TARPs g-2,3
(20%–30%, Figures 2 and 3), the other harbors TARPs
g-8,4,2,3 or GSG1-l (Figures 2, 3, and 5). This inner core of the
AMPARs is complemented by ‘‘outer core’’ constituents binding
directly to theGluA proteins (Figure S6C) at sites distinct from the
interaction sites of the inner core constituents (dashed circles in
orange, Figure 6B): the one TM-domain proteins PRRTs 1,2,
CKAMP44, or C9orf4, as well as the membrane-anchored Neu-
ritin. As an entity, the proteins of the inner and outer core serve as
a platform for other, more peripherally associated AMPAR
constituents including the Noelins, Brorin-2l, and CPT-1 (Fig-
ure 6B); the latter were found tightly correlated with Neuritin
and C9orf4, respectively (Figure S6B).
Together, the arrangement of a common inner core and
variable extensions toward the periphery promotes formation
of AMPARs with the range in size and variability in molecular
composition unraveled by our proteomic analyses (Figures 1–4).
DISCUSSION
We showed that native AMPARs in the adult mammalian brain
are multiprotein assemblies with unanticipated complexity.
Coassembly of the known subunits with the 21 newly identified
constituents into core and periphery of the receptor channels
generates AMPARs with diverse properties and reflects the
complex cell physiology of this main excitatory neurotransmitter
receptor.
The Subunit Assembly of Native AMPARs
For thorough analysis of the building blocks of native AMPARs
we used two complementary approaches, theME-AP procedure
(Figure 1) for identification of the protein constituents and an
advanced BN-MS technique (Figure 2) for determination of their
relative molecular abundance and quantitative analysis of the
subunit assembly. Comprehensiveness and specificity of the
identified AMPAR proteome were ensured by several key
features of the ME-AP approach: (1) the use of multiple ABs
compensating for the pitfalls intrinsic to individual ABs (Mu¨ller
et al., 2010; Schulte et al., 2011), (2) sensitivity and dynamic
range of our nano-LC MS/MS analysis extending over three to
four orders of magnitude (Bildl et al., 2012; Mu¨ller et al., 2010),
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Figure 6. Assembly of Native AMPARs as
Determined by Topology and Binding Prop-
erties of Their Constituents
(A) Topology of all AMPAR constituents (newly
identified proteins in red) and characteristics of
their integration into AMPAR complexes. Color
coding for their abundance and association
stability (from left (minimal) to right (maximal)
derived from the data in Figures 2 and 4) in the
upper-right corner. Specificity denoted for inter-
action with GluA1 or GluA2 is indicated.
(B) Model for the assembly of native AMPARs as
derived from the proteomic (abundance, stoichi-
ometry of CNIHs and TARPs, populations of
AMPARs, Figure 2), biochemical (formation of
distinct complexes, direct interaction with GluAs,
distinct binding characteristics/stabilities of
TARPs g-8 and g-2,3, Figures 2–4, Figure S6C),
and functional analyses (formation of heteromers
from CNIH-2 and GSG1-l, Figures 2 and 5)
described in the text and the present knowledge
from literature/databases. The view of the GluA-
tetramer is from a cross-section of the crystal
structure (Sobolevsky et al., 2009) above the
membrane plane (gray line in A); solid circles in red
and gray depict the suggested asymmetric pairs of
binding sites for the indicated inner core constit-
uents; dashed circles in orange are suggested
binding sites for the indicated outer core compo-
nents PRRTs, CKAMP44, C9orf4, and Neuritin that
interact directly with the GluA proteins (Fig-
ure S6C). The Noelins, Brorin-2l, and CPT-1 are
boxed with Neuritin and C9orf4 with which they
were found tightly correlated (Pearson correlation
analyses, Figure S6B). Dashed line in black delin-
eates periphery/entity of the AMPAR complex;
open circles indicate constituents without yet
defined interaction with the core proteins. AMPAR
constituents for which no further information on
binding or coassembly is in hand were left out.
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knockout animals. In addition, the consistency criterion guaran-
teed reliability of the identified AMPAR constituents. The result-
ing well-defined proteome of the AMPARs from rodent brain
covered the previously known pore-forming and auxiliary
subunits, and in addition identified 21 proteins as novel constit-
uents of AMPAR complexes (Figure 1). Most of them are
secreted or TM proteins of low molecular weight, constraints
imposing intrinsic difficulties on their detection and quantifica-
tion by mass spectrometry.
Subsequent BN-MS analysis provided data on the relative
molecular abundance of individual AMPAR constituents based
on protein quantification by calibration peptides (label-free
QconCAT technique, Figures 2 and 4) and directly visualizedNeuron 74, 621–multiple populations of AMPARs with
different size and molecular composition
(Figure 2). In addition, BN-MS was instru-
mental to monitor the changes in AMPAR
composition induced by the distinct strin-
gencies of solubilization buffers (Figures2 and 4). It is noteworthy that the entire pool of AMPARs was
soluble with buffers of mild/intermediate stringency, in line with
the significant mobility of AMPARs in the synaptic membrane
(Heine et al., 2008), but in marked contrast to NMDA-type gluta-
mate receptors (Figure S2B) or Cav2 channels (Mu¨ller et al.,
2010) that are both embedded into larger protein networks.
Thus, AMPARs are multiprotein complexes of defined size with
an architecture characterized by a common core and variable
periphery (Figure 6B). This core offers two pairs of asymmetric
binding sites that, in the vast majority of AMPARs, are occupied
by different types of auxiliary subunits, TARP g-8 and CNIH-2
being presumably the most abundant combination therein (Fig-
ure 2; also Kato et al., 2010). In fact, at one pair of these sites
the CNIHs compete with TARPs g-2,3, in line with a recent633, May 24, 2012 ª2012 Elsevier Inc. 629
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High-Resolution Architecture of Native AMPARssuggestion (Gill et al., 2011), while the other pair may be occu-
pied by TARPs g-2,3,4,8 or the structurally related GSG1-l
(Figures 6A and 6B). The stability of association observed for
the individual components of core and periphery of the AMPAR
complexes may be quite distinct (Figure 4). Consequently,
comprehensive analysis of the native AMPARs required solubili-
zation with a set of conditions, rather than use of a single buffer
system (Nakagawa et al., 2005; Schulte et al., 2011). In addition,
it should be noted that the presented AMPAR proteome relies on
the sensitivity and dynamic range of our MS analyses. Thus,
proteins interacting with the AMPAR complexes at high
dynamics or proteins with very low or highly select expression
(resulting in protein amounts < 0.1 femtomole) may have
escaped detection (Bildl et al., 2012; Mu¨ller et al., 2010).
Implications for AMPAR Physiology in Excitatory
Synaptic Transmission
About half of the newly identified AMPAR constituents lack any
annotation of primary function(s) in public databases and
scientific literature, while others have not yet been investigated
for their role in AMPAR function. Thus, the results obtained with
the not yet annotated GSG1-l protein are significant in two
aspects: first, they assign GSG1-l the role of an inner core
constituent modifying the gating of AMPARs similar to the
other known auxiliary subunits (Figures 2–5). Second, they
demonstrate the distinct functional consequences generated
by coassembly of different types of auxiliary subunits into
the same AMPAR (Figure 5). This observation emphasizes
the general importance of heteromultimeric assemblies, as
observed with most AMPARs in the brain (Figures 2 and 3),
and indicates that AMPAR functions beyond ligand-driven
channel gating may be largely determined by their non-GluA
constituents.
For a few of the AMPAR constituents identified here, data-
bases and literature offer some striking links toward AMPAR
function and physiology. Thus, the membrane-anchored Neuri-
tin, originally identified as cpg15 in a screen for plasticity-
related genes in the hippocampus (Nedivi et al., 1993), was
shown to promote maturation of synapses supposedly by re-
cruiting AMPARs to the postsynapse (Cantallops et al., 2000).
Similar roles may be expected for LRRT4, a member of the
LRRTM family of proteins recently shown to promote formation
of excitatory synapses (Ko et al., 2009; Linhoff et al., 2009), or
for PRRTs 1,2 that are structurally related to SynDIG1, a protein
involved in the development of excitatory synapses (Kalashni-
kova et al., 2010). Finally, CPT-1 and PORCN are TM proteins
with enzymatic activities involved in palmitoylation of cysteine
residues, a posttranslational modification that was shown to
occur on all GluAs and to modulate receptor trafficking (Haya-
shi et al., 2005); similarly, modulation of AMPAR trafficking
related to synaptic plasticity has been reported for the small
GTP-binding protein Rap-2b (Hussain et al., 2010; Zhu et al.,
2002).
In conclusion, the AMPAR proteome as presented here
defines the molecular framework for the complex cell physiology
of AMPARs in excitatory synaptic transmission and provides
a roadmap for further in-depth structural and functional
investigations.630 Neuron 74, 621–633, May 24, 2012 ª2012 Elsevier Inc.EXPERIMENTAL PROCEDURES
Molecular Biology
Preparation and injection of cRNAs into Xenopus oocytes were done as
described (Fakler et al., 1995). All cDNAs were verified by sequencing;
GenBank accession numbers of the clones used are as follows: M38060.1
(GluA1i, flip variant of GluA1), NM_017261.2 (GluA2i), NM_053351 (TARP
g-2), NM_001025132 (CNIH-2), NM_080696.2 (TARP g-8), XM_574558.2
(GSG1-l), NM_014334.2 (C9orf4), NM_053346.1 (Neuritin), NM_001174086.1
(CKAMP44), and NM_001032285.1 (PRRT1). Characterization of AB-specific
immunoreactivity (Figure S5) was done as described in (Schwenk et al.,
2009).
Biochemistry
Membrane Protein Solubilization
Plasma membrane-enriched protein fractions were prepared from brains
(Berkefeld et al., 2006) of adult rat and mice (pooled from more than 20 WT
and one to four knockout animals, respectively).Membrane proteinswere solu-
bilized for 30 min at 4C with one of the following buffers (at 1 mg protein / ml):
CL-47, CL-48, CL-91, CL-114 (Logopharm GmbH), Triton-buffer (50 mM
Tris/HCl pH 8.0 / 150 mM NaCl / 1% Triton X-100), or RIPA-buffer (50 mM
Tris/HCl pH 7.4 / 150 mM NaCl / 1% NP40 / 0.5% Deoxycholate / 0.1%
SDS); each buffer was supplemented with freshly added protease inhibitors.
Nonsolubilized material was subsequently removed by ultracentrifugation
(10 min at 150,000 3 g). The efficiency of solubilization was controlled by
western blot analysis of SDS-PAGE resolved aliquots of the soluble fraction
(supernatant) and the pellets.
Analytical BN-PAGE
Two-dimensional BN-PAGE/SDS-PAGE separations were essentially done as
described (Schwenk et al., 2009). Protein complexeswere solubilized inCL-47,
CL-48, or CL-91 and centrifuged on a sucrose gradient (400,0003 g, 60min) to
replace salt by 0.5 M betaine. For AB-shift experiments the solubilisates were
preincubatedwith the respective ABs for 30min on ice. After addition of 0.05%
Coomassie G250 the samples were separated on linear 3%–8% or 3%–15%
polyacrylamide gradient gels in 15 mM BisTris / 50 mM Tricine / 0.01% Coo-
massie G250 running buffer and 15 mM BisTris (pH 7.0) as anode buffer. A
mixture of native proteins (GE Healthcare, USA) and rat mitochondrial
membrane protein complexes (Wittig et al., 2010) were run as a standard for
complex size in the first dimension. Excised BN-PAGE lanes were incubated
for 15 min in Laemmli buffer and placed on top of 10% or 15% SDS-PAGE
gels. After electroblotting on PVDF membranes the blot was cut horizontally
into different molecular weight ranges and stained with the indicated ABs.
Preparative BN-PAGE
For BN-MS analysis, protein complexes were solubilized from 3 mg (CL-47) or
1 mg (CL-48) rat brain membranes and prepared as detailed above. Samples
were resolved on linear 1%–11% polyacrylamide gels (2.5 cm lanes) using the
described BN-PAGE buffer system, and the respective gel lanes were
collected and frozen at 20C. The section of interest (3 3 2 cm) was
trimmed, frozen, and sliced in 0.4 mm sections on a cryomicrotome (Leica
CM 1950). Slices were thoroughly washed with fixative (30% ethanol / 15%
acetic acid) and subjected to in-gel tryptic digestion (81 slices for CL-47 and
69 slices for CL-48 separations).
Affinity Purifications
Solubilisates (1.5 ml) were directly incubated with 10 mg immobilized ABs at
4C for 2 hr. The following ABs were used for affinity purifications: anti-
GluA1-a (Millipore, #AB1504), anti-GluA1-b (Synaptic System, #182-003),
anti-GluA1-c (Synaptic System, #182-011), anti-GluA2-a (Millipore,
#AB1768), anti-GluA2-b (NeuroMab, #75-002), anti-GluA2-c (Santa Cruz,
#sc7610), anti-GluA2/3 (Millipore, #07-598), anti-GluA3 (Synaptic System,
#182-203), anti-GluA4-a (Millipore, #AB1508), anti-GluA4-b (Santa Cruz,
#sc-7614), anti-CNIH-2/3 (Hoshino et al., 2007), anti-TARP g-8 (Frontier Insti-
tute, RBAf1000-1), anti-TARP g-2 (Upstate, #07-577), anti-CKAMP44 (kind gift
of Dr. R. Sprengel, von Engelhardt et al., 2010), anti-GSG1-like (raised in rabbit
against aa 257-278 of Swiss-Prot accession Q6UXU4, affinity purified), anti-
PRRT1 (raised in rabbit against aa 36-54 of Swiss-Prot accession Q6MG82,
affinity purified), anti-Noelin1 (R&DSystems, #AF4636), and anti-FLAG (Sigma,
#F3165). After brief washing with the respective detergent buffer bound
Neuron
High-Resolution Architecture of Native AMPARsproteins were eluted with Laemmli buffer (DTT added after elution). Isolated
proteins were shortly run into SDS-PAGE gels, silver stained, cut in two pieces
of MW > 50 and MW < 50 kDa, and in-gel digested with trypsin (Pandey and
Mann, 2000).
Western analyses were performed with anti-GluA1-a, anti-GluA2 (Millipore,
MAB397), anti-GluA2/3, anti-GluA3, anti-GluA4-a, anti-TARP g-2, anti-TARP
g-8, anti-CKAMP44, anti-GSG1-like (Sigma, #HPA014479), and anti-CNIH-
2/3 ABs. The AB-stained bands were visualized by anti-mouse, -rabbit,
-goat IgG-HRP (all Santa Cruz), and ECL+ (GE Healthcare).
QconCAT Calibration Standard
Two to six consistent peptides specific for each of the identified AMPAR
constituents (Table S4) as well as three control proteins were selected and
randomly fused in silico to form three N- and C-terminally tagged standard
(QconCAT) proteins (84, 60, and 82 peptides resulting in QconCAT proteins
of 907 aa, 743 aa, and 942 aa, respectively). The corresponding gene
sequences were synthesized (GenScript) and subcloned in a modified
pET16 vector; calibration proteins were expressed in Escherichia coli
BL21(DE3). After verification of full-length expression by dual western blots
using anti-tag ABs, two-fold dilutions of the QconCAT proteins (seven to
nine steps) were separated by SDS-PAGE. The corresponding protein bands
were visualized by Coomassie staining, excised, and separately digested by
trypsin for subsequent triplicate mass spectrometric analysis.
Mass Spectrometry
LC-MS/MS Analysis
Extracted postdigest peptide mixtures dissolved in 0.5% (v/v) trifluoroacetic
acid were analyzed by nano-LC-MS/MS with a LTQ FT Ultra mass spectrom-
eter as described (Mu¨ller et al., 2010). Precursor signals were acquired with
a target value of 1,000,000 and a nominal resolution of 100,000 (FWHM) at
m/z 400 (scan range 370 to 1700m/z). Up to five data-dependent CID fragment
spectra per scan cycle were acquired in the ion trap with a target value of
10,000 (maximum injection time 400 ms) with dynamic exclusion enabled.
Total MS acquisition times were 105 min (75 min rising acetonitrile concentra-
tion, 30 s dynamic MS/MS exclusion) for AP eluate fractions and 170 min
(140 min rising acetonitrile concentration, 60 s dynamic MS/MS exclusion)
for BN-PAGE fractions, respectively.
Database Search
LC-MS/MS data was extracted using the extract_msn utility and searched
against the UniProt Knowledgebase release 2010_11 using theMascot search
engine (version 2.3.01; Matrix Science) with tolerance for peptide mass and
fragment mass set to 15 ppm and 0.8 ppm, respectively. One missed trypsin
cleavage and common variable modifications were accepted for peptide iden-
tification. After linear shift mass recalibration the peptide mass window was
narrowed to ± 5 ppm for final searches. The final search database contained
all UniProtKB/Swiss-Prot entries for Mus musculus, Rattus norvegicus, and
Homo sapiens including P00761, P00766, P02769, P11886, and P41921 as
well as 22 UniProtKB/TrEMBL homologs to previously (in the course of this
study) identified AMPAR complex constituents of these species. Proteins
identified by only one specific MS/MS spectrum were not further considered.
The average effective peptide FDR for all evaluated proteins (calculated as the
number of corresponding peptides identified with a Mascot ion score R 20
for the real database versus respective hits in a decoy database) was 0.029
(SD 0.021).
Relative Amino Acid Sequence Coverage
Relative amino acid sequence coverage of proteins (Figures 1D and Table S2)
was calculated as SC = Ni / (Ni + Nan), where Ni is the number of amino acid
residues covered by identified peptides (Mascot e-value < 0.05, retrieval in > 2
independent APs) and Nan is the number of MS-accessible (peptides within
740 < MW < 3,000 with trypsin cleavage C-terminal to the basic amino acids,
but not N-terminal to proline; missed cleavages were not considered) but not
identified amino acids in the respective database sequence.
Protein Quantification Procedures
For peak volume-based quantification, m/z features along LC-MS scans were
detected and quantified (as intensity 3 retention time 3 m/z width) using
msInspect (Computational Proteomics Laboratory, Fred Hutchinson Cancer
Research Center, Seattle, WA, USA). After correction of m/z shifts (based on
MS-sequenced peptides using an in-house written script), features werealigned between different LC-MS/MS runs and assigned to the peptides iden-
tified by Mascot (retention time tolerance: 3% or 1 min, m/z difference
threshold: ± 5 ppm). The resulting peptide peak volumes (PVs) were used for
two different quantification procedures.
Protein Abundance Ratios (rPV). In AP versus control (Figure 1), these were
determined using the TopCorr method detailed in (Bildl et al., 2012; Supple-
mental Experimental Procedures). Protein rPV values were plotted for each
AB (AP versus controls, e.g., Figure 1B) to derive specificity thresholds from
the resulting ratio distributions. Proteins were considered specifically copuri-
fied when rPV(versus IgG) > threshold(IgG) in both rat and mouse, and no
cross-reactivity was indicated by rPV(versus KO) < threshold(versus KO)
(Figure 1).
Relative Molar Abundances of Proteins. In a sample (Figures 2 and 4), these
were determined as follows: dilution series of the QconCAT proteins (total of
171 peptides, see above) were measured by LC-MS/MS three times and the
extracted peptide PVs checked for reproducibility and linearity over at least
two orders of magnitude. For each peptide slope factors were determined
by linear regression fits to the measured PVs versus dilution factor of the
load reflecting each peptide’s specific MS signal intensity (Figure S2; loads
of the three concatenated standards were normalized to each other by their
abundancenorm values; Zolles et al., 2009). These slope factors were then
used to normalize the respective peptide PVs in APs or BN-PAGE slices to
an equimolar basis. The relative molar abundance of each protein was then
calculated as intensity-weighted mean (AP data sets) or median (BN-PAGE
samples) of the respective normalized peptide PVs. To establish protein
profiles across BN-PAGE samples (Figure 2), the respective PV tables were
preprocessed: (1) each individual slice measurement (i.e., LC-MS data set)
was scaled by dividing its average PV to a sliding average PV of the neigh-
boring two slices (window of 5) to account for variations in slice thickness,
peptide recovery and LC-MS sensitivity and (2) a filter was applied to eliminate
false-positive PV assignments (identified as solitary values without backup
from the neighboring two slices or > 10-fold outliers with respect to the
average of corresponding PVs in the neighboring two slices) and to bridge
gaps resulting from false-negative assignments (individual missing values
were replaced by the corresponding PV average of the neighboring slices, if
available). The resulting relative molar protein abundances were finally
smoothened by averaging (window of 3).
Electron Microscopy
Hippocampal sections of adult Wistar rats (CA3 area, 80 nm thick) were pro-
cessed for the postembedding immunogold labeling as described earlier (Kulik
et al., 2002; Schwenk et al., 2009) and stained with affinity-purified mouse
anti-GluA2/4 (Millipore, #MAB396) and two different rabbit anti-GSG1-l ABs
(raised against aa 83-102 and aa 257-278; Figure S5B). Secondary ABs
(1:20; British Biocell International, Cardiff, UK) were coupled to either 10 nm
gold particles (for GluR2/4) or 15 nm gold particles (for GSG1-l).
Electrophysiological Recordings and Data Analysis
Electrophysiological recordings from giant outside-out patches excised from
oocytes were performed at room temperature (22C –24C) as described
previously (Berkefeld et al., 2006). Currents were recorded with an EPC9
amplifier, low-pass filtered at 3 kHz and sampled at 5–10 kHz. Pipettes
made from thick-walled borosilicate glass had resistances of 0.4–0.8 MU
when filled with intracellular solution (Kint; in mM) 120 KCl, 5 HEPES, 10
EGTA, pH adjusted to 7.2. Extracellular solution (Kext) applied to outside-out
patches was composed as follows (mM): 120 KCl, 5 HEPES, 1.3 CaCl2
(pH 7.2). Rapid application/removal of glutamate (1 mM, dissolved in Kex)
was performed using a Piezo-controlled fast application system with
a double-barrel application pipette that enables solution exchanges within
less than 100 ms (20%–80%, measured from the open tip response during
a switch between normal and 103-diluted Kext).
Deactivation, desensitization, and recovery from desensitization of AMPARs
were characterized by time constants derived frommonoexponential fits to the
decay phase or recovery of the glutamate-activated currents; the quality of the
fit result was judged from the sum of squared differences value. Curve fitting
and further data analysis were done with Igor Pro 4.05A Carbon. Data in text
and figures are given as mean ± SD, unless specified differently.Neuron 74, 621–633, May 24, 2012 ª2012 Elsevier Inc. 631
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